Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Fanconi Anemia and RAD51C[original query] |
|---|
| Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast cancer research and treatment 2010 Dec 124 (3): 857-61. Zheng Yonglan, Zhang Jing, Hope Kisha, Niu Qun, Huo Dezheng, Olopade Olufunmilayo |
| Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nature genetics 2010 May 42 (5): 410-4. Meindl Alfons, Hellebrand Heide, Wiek Constanze, Erven Verena, Wappenschmidt Barbara, Niederacher Dieter, Freund Marcel, Lichtner Peter, Hartmann Linda, Schaal Heiner, Ramser Juliane, Honisch Ellen, Kubisch Christian, Wichmann Hans E, Kast Karin, Deissler Helmut, Engel Christoph, Müller-Myhsok Bertram, Neveling Kornelia, Kiechle Marion, Mathew Christopher G, Schindler Detlev, Schmutzler Rita K, Hanenberg Helm |
| Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Breast cancer research and treatment 2011 Dec 130 (3): 1003-10. Vuorela Mikko, Pylkäs Katri, Hartikainen Jaana M, Sundfeldt Karin, Lindblom Annika, von Wachenfeldt Wäppling Anna, Haanpää Maria, Puistola Ulla, Rosengren Annika, Anttila Maarit, Kosma Veli-Matti, Mannermaa Arto, Winqvist Robe |
| RAD51C is a susceptibility gene for ovarian cancer. Human molecular genetics 2011 Aug 20 (16): 3278-88. Pelttari Liisa M, Heikkinen Tuomas, Thompson Deborah, Kallioniemi Anne, Schleutker Johanna, Holli Kaija, Blomqvist Carl, Aittomäki Kristiina, Bützow Ralf, Nevanlinna He |
| Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population. Molecular oncology 2013 Feb 7 (1): 85-100. Litim Nadhir, Labrie Yvan, Desjardins Sylvie, Ouellette Geneviève, Plourde Karine, Belleau Pascal, , Durocher Franci |
| RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families. Breast cancer research and treatment 2014 Aug 147 (1): 133-43. Blanco Ana, Gutiérrez-Enríquez Sara, Santamariña Marta, Montalban Gemma, Bonache Sandra, Balmaña Judith, Carracedo Angel, Diez Orland, Vega A |
| Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan. Breast cancer research and treatment 2014 Jun 145 (3): 775-84. Rashid Muhammad U, Muhammad Noor, Faisal Saima, Amin Asim, Hamann U |
| Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Breast cancer research and treatment 2020 Jun . Alter Blanche P, Best Ana |
| Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients. Cancers 2020 4 12 (4): . Del Valle Jesús, Rofes Paula, Moreno-Cabrera José Marcos, López-Dóriga Adriana, Belhadj Sami, Vargas-Parra Gardenia, Teulé Àlex, Cuesta Raquel, Muñoz Xavier, Campos Olga, Salinas Mónica, de Cid Rafael, Brunet Joan, González Sara, Capellá Gabriel, Pineda Marta, Feliubadaló Lídia, Lázaro Con |
| Spectrum of Germline Mutations Within Fanconi Anemia-Associated Genes Across Populations of Varying Ancestry. JNCI cancer spectrum 2022 8 5 (1): . Chan Sock Hoai, Ni Ying, Li Shao-Tzu, Teo Jing Xian, Ishak Nur Diana Binte, Lim Weng Khong, Ngeow Joan |
| A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer. Journal of cancer research and clinical oncology 2023 8 . Qiao-Yan Zhu, Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Rong Wang, Xiao-Lin Li, Wei-Wu Ye, Xiao-Wen Ding, Xiao-Jia Wang, Wen-Ming C |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 11, 2023
- Content source: